Intermittent Preventive Treatment: Clinical Trials

3 trials for Intermittent Preventive Treatment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 withdrawn. 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Not yet recruiting 1
Phase 41Withdrawn 1

Follow Intermittent Preventive Treatment: new trials by email Literature Review of Intermittent Preventive Treatment trials Research Report on Intermittent Preventive Treatment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren
Monthly DP, Quarterly DP - Malaria, Asymptomatic Malaria
Phase 3Not yet recruitingIndiana University15002028-01-012026-09-01
Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda
Sulfadoxine-pyrimethamine - Intermittent Preventive Treatment, Placental Malaria
Phase 4WithdrawnUniversity of California, San Francisco2010-10-012015-03-05
Intermittent Preventive Treatment of Malaria in Schoolchildren
sulfadoxine-pyrimethamine, amodiaquine + sulfadoxine-pyrimethamine, dihydroartemisinin-piperaquine - Malaria, Intermittent Preventive Treatment
Phase 3CompletedLondon School of Hygiene and Tropical Medicine7802008-02-012024-03-21

Narrower conditions

Malaria (3)  ·  Anemia (1)  ·  Inflammation (1)  ·  Literacy (1)  ·  Malaria, Falciparum (1)

Broader conditions

Infections (3)  ·  Mosquito-Borne Diseases (3)  ·  Parasitic Diseases (3)  ·  Protozoan Infections (3)  ·  Vector Borne Diseases (3)  ·  Behavior (1)  ·  Communication (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

fanasil, pyrimethamine drug combination (2)  ·  Amodiaquine (1)

Sponsors

Indiana University (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  University of California, San Francisco (1)

Countries

Uganda (1)

Top investigators

Eren Oyungu, MBChB, MMED (1)  ·  Megan S McHenry, MD, MS (1)  ·  Moses Kamya, MBChB, MMed, MPH, PhD (1)  ·  Sarah G Staedke, MD (1)  ·  Scott Filler, MD, DTM&H (1)  ·  Veronica Ades, MD, MPH (1)

Results publications

PMID 20976051